GENERATE BIOMEDICINES INC (GENB) Stock Cash Flow
NASDAQ:GENB • US3709201004
Current stock price
13.15 USD
+0.52 (+4.12%)
At close:
13.3 USD
+0.15 (+1.14%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | ||||
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net Income | -223.00M | -181.00M | |||
| Depreciation Amortization | 13.00M | 15.00M | |||
| Change In Working Capital | -15.00M | 28.00M | |||
| Other non cash items | 24.00M | 20.00M | |||
| OPERATING CASH FLOW | -201.00M | -118.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Capital Expenditure | -3.51M | -3.45M | |||
| Other Investing Activity | 120.00M | -54.00M | |||
| INVESTING CASH FLOW | 117.00M | -58.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Debt Issued/Reduced | -8.16M | -11.00M | |||
| Stock Issued/Repurchased | 23.00M | 97.00M | |||
| Other Financing Activity | 13.00M | 5.00M | |||
| FINANCING CASH FLOW | 28.00M | 91.00M | |||
| CHANGE IN CASH | -56.00M | -85.00M | |||
| FREE CASH FLOW | |||||
| Operating Cash Flow | -201.00M | -118.00M | |||
| Capital Expenditure | -3.51M | -3.45M | |||
| FREE CASH FLOW | -204.51M | -121.45M | |||
All data in USD